Log in to your Inderes Free account to see all free content on this page.
Senzime
5.8
SEK
+2.29 %
SEZI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
2 following
+2.29%
+1.75%
-5.54%
-23.48%
-21.94%
-1.36%
-70.6%
-63.25%
-2.27%
Senzime is a medical technology company. The company develops technology solutions that make it possible to follow biochemical and physiological processes before, during and after surgery. The portfolio includes systems used to automate and measure the substances glucose and lactate in blood and tissues. In addition to the main services, digital systems are also offered and developed for monitoring patients' conditions during anesthesia treatment. The company's head office is located in Uppsala.
Read moreMarket cap
772.41M SEK
Turnover
488.59K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
17.2.
2025
Annual report '24
7.5.
2025
Interim report Q1'25
19.5.
2025
General meeting '24
ShowingAll content types
Carnegie Commissioned Research: [Correction] Senzime: Interview - Q3 presentation and Q&A
Carnegie Commissioned Research: Senzime: Interview - Q3 presentation and Q&A
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio